252 related articles for article (PubMed ID: 18583715)
1. Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model.
Rizzi N; Liu N; Napolitano C; Nori A; Turcato F; Colombi B; Bicciato S; Arcelli D; Spedito A; Scelsi M; Villani L; Esposito G; Boncompagni S; Protasi F; Volpe P; Priori SG
Circ Res; 2008 Aug; 103(3):298-306. PubMed ID: 18583715
[TBL] [Abstract][Full Text] [Related]
2. Post-natal heart adaptation in a knock-in mouse model of calsequestrin 2-linked recessive catecholaminergic polymorphic ventricular tachycardia.
Valle G; Boncompagni S; Sacchetto R; Protasi F; Volpe P
Exp Cell Res; 2014 Feb; 321(2):178-89. PubMed ID: 24370574
[TBL] [Abstract][Full Text] [Related]
3. Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age.
Denegri M; Bongianino R; Lodola F; Boncompagni S; De Giusti VC; Avelino-Cruz JE; Liu N; Persampieri S; Curcio A; Esposito F; Pietrangelo L; Marty I; Villani L; Moyaho A; Baiardi P; Auricchio A; Protasi F; Napolitano C; Priori SG
Circulation; 2014 Jun; 129(25):2673-81. PubMed ID: 24888331
[TBL] [Abstract][Full Text] [Related]
4. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.
Song L; Alcalai R; Arad M; Wolf CM; Toka O; Conner DA; Berul CI; Eldar M; Seidman CE; Seidman JG
J Clin Invest; 2007 Jul; 117(7):1814-23. PubMed ID: 17607358
[TBL] [Abstract][Full Text] [Related]
5. Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: effects of CASQ2 mutations linked to sudden cardiac death.
Terentyev D; Kubalova Z; Valle G; Nori A; Vedamoorthyrao S; Terentyeva R; Viatchenko-Karpinski S; Bers DM; Williams SC; Volpe P; Gyorke S
Biophys J; 2008 Aug; 95(4):2037-48. PubMed ID: 18469084
[TBL] [Abstract][Full Text] [Related]
6. Viral gene transfer rescues arrhythmogenic phenotype and ultrastructural abnormalities in adult calsequestrin-null mice with inherited arrhythmias.
Denegri M; Avelino-Cruz JE; Boncompagni S; De Simone SA; Auricchio A; Villani L; Volpe P; Protasi F; Napolitano C; Priori SG
Circ Res; 2012 Mar; 110(5):663-8. PubMed ID: 22298808
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of calsequestrin regulation of single cardiac ryanodine receptor in normal and pathological conditions.
Chen H; Valle G; Furlan S; Nani A; Gyorke S; Fill M; Volpe P
J Gen Physiol; 2013 Aug; 142(2):127-36. PubMed ID: 23858002
[TBL] [Abstract][Full Text] [Related]
8. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death.
Terentyev D; Nori A; Santoro M; Viatchenko-Karpinski S; Kubalova Z; Gyorke I; Terentyeva R; Vedamoorthyrao S; Blom NA; Valle G; Napolitano C; Williams SC; Volpe P; Priori SG; Gyorke S
Circ Res; 2006 May; 98(9):1151-8. PubMed ID: 16601229
[TBL] [Abstract][Full Text] [Related]
9. Abnormal propagation of calcium waves and ultrastructural remodeling in recessive catecholaminergic polymorphic ventricular tachycardia.
Liu N; Denegri M; Dun W; Boncompagni S; Lodola F; Protasi F; Napolitano C; Boyden PA; Priori SG
Circ Res; 2013 Jul; 113(2):142-52. PubMed ID: 23674379
[TBL] [Abstract][Full Text] [Related]
10. New roles of calsequestrin and triadin in cardiac muscle.
Knollmann BC
J Physiol; 2009 Jul; 587(Pt 13):3081-7. PubMed ID: 19451205
[TBL] [Abstract][Full Text] [Related]
11. Impaired Dynamic Sarcoplasmic Reticulum Ca Buffering in Autosomal Dominant CPVT2.
Wleklinski MJ; Kryshtal DO; Kim K; Parikh SS; Blackwell DJ; Marty I; Iyer VR; Knollmann BC
Circ Res; 2022 Sep; 131(8):673-686. PubMed ID: 36102198
[TBL] [Abstract][Full Text] [Related]
12. Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background.
Kalyanasundaram A; Viatchenko-Karpinski S; Belevych AE; Lacombe VA; Hwang HS; Knollmann BC; Gyorke S; Periasamy M
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H253-61. PubMed ID: 21984545
[TBL] [Abstract][Full Text] [Related]
13. An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of
Ng K; Titus EW; Lieve KV; Roston TM; Mazzanti A; Deiter FH; Denjoy I; Ingles J; Till J; Robyns T; Connors SP; Steinberg C; Abrams DJ; Pang B; Scheinman MM; Bos JM; Duffett SA; van der Werf C; Maltret A; Green MS; Rutberg J; Balaji S; Cadrin-Tourigny J; Orland KM; Knight LM; Brateng C; Wu J; Tang AS; Skanes AC; Manlucu J; Healey JS; January CT; Krahn AD; Collins KK; Maginot KR; Fischbach P; Etheridge SP; Eckhardt LL; Hamilton RM; Ackerman MJ; Noguer FRI; Semsarian C; Jura N; Leenhardt A; Gollob MH; Priori SG; Sanatani S; Wilde AAM; Deo RC; Roberts JD
Circulation; 2020 Sep; 142(10):932-947. PubMed ID: 32693635
[TBL] [Abstract][Full Text] [Related]
14. Gene Transfer of Engineered Calmodulin Alleviates Ventricular Arrhythmias in a Calsequestrin-Associated Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia.
Liu B; Walton SD; Ho HT; Belevych AE; Tikunova SB; Bonilla I; Shettigar V; Knollmann BC; Priori SG; Volpe P; Radwański PB; Davis JP; Györke S
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720499
[TBL] [Abstract][Full Text] [Related]
15. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.
Viatchenko-Karpinski S; Terentyev D; Györke I; Terentyeva R; Volpe P; Priori SG; Napolitano C; Nori A; Williams SC; Györke S
Circ Res; 2004 Mar; 94(4):471-7. PubMed ID: 14715535
[TBL] [Abstract][Full Text] [Related]
16. Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice.
Chopra N; Kannankeril PJ; Yang T; Hlaing T; Holinstat I; Ettensohn K; Pfeifer K; Akin B; Jones LR; Franzini-Armstrong C; Knollmann BC
Circ Res; 2007 Sep; 101(6):617-26. PubMed ID: 17656677
[TBL] [Abstract][Full Text] [Related]
17. Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.
Alcalai R; Wakimoto H; Arad M; Planer D; Konno T; Wang L; Seidman JG; Seidman CE; Berul CI
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):316-24. PubMed ID: 20807279
[TBL] [Abstract][Full Text] [Related]
18. Catecholaminergic polymorphic ventricular tachycardia-related mutations R33Q and L167H alter calcium sensitivity of human cardiac calsequestrin.
Valle G; Galla D; Nori A; Priori SG; Gyorke S; de Filippis V; Volpe P
Biochem J; 2008 Jul; 413(2):291-303. PubMed ID: 18399795
[TBL] [Abstract][Full Text] [Related]
19. The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling.
Kirchhefer U; Wehrmeister D; Postma AV; Pohlentz G; Mormann M; Kucerova D; Müller FU; Schmitz W; Schulze-Bahr E; Wilde AA; Neumann J
J Mol Cell Cardiol; 2010 Jul; 49(1):95-105. PubMed ID: 20302875
[TBL] [Abstract][Full Text] [Related]
20. The cardiac ryanodine receptor luminal Ca2+ sensor governs Ca2+ waves, ventricular tachyarrhythmias and cardiac hypertrophy in calsequestrin-null mice.
Zhang J; Chen B; Zhong X; Mi T; Guo A; Zhou Q; Tan Z; Wu G; Chen AW; Fill M; Song LS; Chen SR
Biochem J; 2014 Jul; 461(1):99-106. PubMed ID: 24758151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
